Gregory M Pontone

Gregory M Pontone, MD, MHS

Division Chief And Professor Of Aging, Behavioral, And Cognitive Neurology And Co-Director Of The Fixel Neuropsychiatry Program

Department: MD-BEHAVIORAL NEUROLOGY
Business Phone: (352) 294-5000
Business Email: gpontone@ufl.edu

About Gregory M Pontone

My name is Gregory Pontone, MD, MHS, and I am chief of the University of Florida Aging, Behavioral and Cognitive (ABC) Neurology Division. I earned my medical degree from the University of South Florida in Tampa. After medical school, I completed a medical internship at Johns Hopkins Bayview followed by a residency in psychiatry and a fellowship in geriatric psychiatry and movement disorders research at The Johns Hopkins Hospital in Baltimore, Maryland.

Prior to joining UF Health, I was an associate professor of psychiatry and behavioral sciences at The Johns Hopkins Hospital, where I co-founded and directed a movement disorder clinic that provided comprehensive psychiatric care for patients with Parkinsons disease and related neurological disorders. I also co-founded a mental health counseling program that extended care to spouses, families and caregivers of patients with neurological disorders.

My clinical interests surround caring for patients with Parkinsons disease who also suffer from cognitive impairment and psychiatric disorders.

As a physician, my goal is to provide the most up-to-date, evidence-based treatments for cognitive and psychiatric disorders that occur in patients with Parkinsons disease. In order to improve care for the future, I provide access to clinical trials and research that advances knowledge regarding the diagnosis, treatment and mechanistic causes of cognitive impairment and psychiatric disorders in Parkinsons disease. Lastly, I am dedicated to reducing the stigma associated with psychiatric diagnoses by providing education to combat misunderstanding and fear.

In my free time, I enjoy playing basketball and tennis, bicycling and reading.

Accomplishments

Mentoring Award for supporting the research career of a junior faculty member
2019 · Brigham and Women's Hospital
Parkinson Study Group, Visiting Mentorship Award
2019 · Sunovion Pharmaceuticals
Highest Score on Graduate Training Program in Clinical Investigation Comprehensive Exam
2016 · Johns Hopkins University School of Medicine
NEMA Clinical Researcher Awards
2016 · National Electrical Manufacturers Association

Board Certifications

  • Geriatric Psychiatry
    American Board of Psychiatry and Neurology
  • Psychiatry
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties
  • Clinical Neuropsychology
Subspecialties
  • Behavioral Neurology and Neuropsychiatry
  • Geriatric Psychiatry
Areas of Interest
  • Parkinson disease

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-9540-6913

Publications

2024
Defining the Importance of Minor Hallucinations in Parkinson’s Disease.
Movement disorders : official journal of the Movement Disorder Society. 39(6) [DOI] 10.1002/mds.29840. [PMID] 38922987.
2024
Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
Journal of Alzheimer's disease : JAD. 99(1):101-103 [DOI] 10.3233/JAD-240328. [PMID] 38669552.
2024
Gaps and Controversies in Catatonia as a Movement Disorder.
Movement disorders : official journal of the Movement Disorder Society. [DOI] 10.1002/mds.29906. [PMID] 38924566.
2024
Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson’s Disease.
Movement disorders clinical practice. 11(5):534-542 [DOI] 10.1002/mdc3.14017. [PMID] 38470011.
2024
On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis
CNS Drugs. 38(5):333-347 [DOI] 10.1007/s40263-024-01084-1. [PMID] 38587586.
2024
Real or imagined: We need a new scale for psychosis in Parkinson’s disease.
Parkinsonism & related disorders. 121 [DOI] 10.1016/j.parkreldis.2024.106004. [PMID] 38278654.
2024
The Association of Antidepressant Use and Impulse Control Disorder in Parkinson’s Disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 32(6):710-720 [DOI] 10.1016/j.jagp.2023.12.024. [PMID] 38238235.
2023
A Prescription for Wellness in Early PD: Just What the Doctor Ordered.
Journal of geriatric psychiatry and neurology. 36(6):461-469 [DOI] 10.1177/08919887231164358. [PMID] 36911924.
2023
A Wellness Prescription for Parkinson’s: Mid to Late-Stage Disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 31(9):737-747 [DOI] 10.1016/j.jagp.2023.02.049. [PMID] 37005185.
2023
Association of caregiver strain with the trajectory of quality of life in Parkinson’s disease.
Parkinsonism & related disorders. 108 [DOI] 10.1016/j.parkreldis.2023.105292. [PMID] 36702071.
2023
Examining the link between impulse control disorder and antidepressant use in Parkinson’s disease.
Parkinsonism & related disorders. 117 [DOI] 10.1016/j.parkreldis.2023.105918. [PMID] 37922636.
2023
Invited Perspective on “BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study” (Cognat et al. 2023): Roles for nosology and neurobiology in understanding the heterogeneity of BPSD.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 31(8):640-642 [DOI] 10.1016/j.jagp.2023.04.009. [PMID] 37210250.
2023
Levetiracetam for the treatment of mild cognitive impairment in Parkinson’s disease: a double-blind controlled proof-of-concept trial protocol.
Pilot and feasibility studies. 9(1) [DOI] 10.1186/s40814-023-01406-y. [PMID] 37993889.
2023
NPTX2 in Cerebrospinal Fluid Predicts the Progression From Normal Cognition to Mild Cognitive Impairment.
Annals of neurology. 94(4):620-631 [DOI] 10.1002/ana.26725. [PMID] 37345460.
2023
Reconceptualizing Catatonia as “Psychiatric Parkinsonism”
The American Journal of Geriatric Psychiatry. 31(12):1206-1208 [DOI] 10.1016/j.jagp.2023.07.010.
2023
Staying hidden: The burden of stigma in PD.
Parkinsonism & related disorders. 116 [DOI] 10.1016/j.parkreldis.2023.105838. [PMID] 37689498.
2023
The impact of caregiving on quality of life in Parkinson’s disease: A systematic review.
International journal of geriatric psychiatry. 38(1) [DOI] 10.1002/gps.5870. [PMID] 36703272.
2022
APOE4 Allele, Sex, and Dementia Risk in Parkinson’s Disease: Lessons From a Longitudinal Cohort.
Journal of geriatric psychiatry and neurology. 35(6):810-815 [DOI] 10.1177/08919887211060019. [PMID] 34958617.
2022
Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson’s Disease.
Journal of geriatric psychiatry and neurology. 35(3):353-362 [DOI] 10.1177/0891988721996802. [PMID] 33622073.
2022
Invited Perspective on “Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson’s Disease: Longitudinal Mediation Analyses”.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 30(6):675-677 [DOI] 10.1016/j.jagp.2021.12.004. [PMID] 34980552.
2022
Invited Perspective on the “Long-Term Efficacy and Safety of Zonisamide for Treatment of Parkinsonism in Patients With Dementia With Lewy Bodies: An Open-label Extension of a Phase 3 Randomized Controlled Trial”.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 30(3):329-331 [DOI] 10.1016/j.jagp.2021.07.017. [PMID] 34429237.
2022
Phenomenology of Atypical Anxiety Disorders in Parkinson’s Disease: A Systematic Review.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 30(9):1026-1050 [DOI] 10.1016/j.jagp.2022.02.004. [PMID] 35305884.
2022
The Dawn of Precision Medicine for Deep Brain Stimulation in Parkinson’s Disease?
Movement disorders : official journal of the Movement Disorder Society. 37(11) [DOI] 10.1002/mds.29224. [PMID] 36103399.
2022
‘Anxious fluctuators’ a subgroup of Parkinson’s disease with high anxiety and problematic on-off fluctuations
Parkinsonism & Related Disorders. 105:62-68 [DOI] 10.1016/j.parkreldis.2022.11.002. [PMID] 36371868.
2021
Anxiety in Parkinson’s Disease: A Systematic Review of Neuroimaging Studies.
The Journal of neuropsychiatry and clinical neurosciences. 33(4):280-294 [DOI] 10.1176/appi.neuropsych.20110272. [PMID] 34280319.
2021
Apathy and Anxiety in De Novo Parkinson’s Disease Predict the Severity of Motor Complications.
Movement disorders clinical practice. 8(1):76-84 [DOI] 10.1002/mdc3.13117. [PMID] 33426161.
2021
Attentional dysfunction and the punding spectrum in Parkinson’s disease.
Parkinsonism & related disorders. 84:23-28 [DOI] 10.1016/j.parkreldis.2021.01.019. [PMID] 33545553.
2021
Brainstem Pathologies Correlate With Depression and Psychosis in Parkinson’s Disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 29(9):958-968 [DOI] 10.1016/j.jagp.2020.12.009. [PMID] 33455856.
2021
Hippocampal correlates of episodic memory in Parkinson’s disease: A systematic review of magnetic resonance imaging studies.
Journal of neuroscience research. 99(9):2097-2116 [DOI] 10.1002/jnr.24863. [PMID] 34075634.
2021
Invited Perspective on the “Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson’s Disease”.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 29(1):48-50 [DOI] 10.1016/j.jagp.2020.05.030. [PMID] 32622729.
2021
Mind the gap: Inequalities in mental health care and lack of social support in Parkinson disease.
Parkinsonism & related disorders. 93:97-102 [DOI] 10.1016/j.parkreldis.2021.11.015. [PMID] 34887173.
2021
Optimal Treatment of Depression and Anxiety in Parkinson’s Disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 29(6):530-540 [DOI] 10.1016/j.jagp.2021.02.037. [PMID] 33648830.
2021
Pseudo-Wellens syndrome from sepsis-induced cardiomyopathy: a case report and review of the literature.
Journal of medical case reports. 15(1) [DOI] 10.1186/s13256-021-02756-y. [PMID] 33820566.
2021
Psychomotor processing and functional decline in Parkinson’s disease predicted by the Purdue Pegboard test.
International journal of geriatric psychiatry. 36(6):909-916 [DOI] 10.1002/gps.5492. [PMID] 33426751.
2020
A call for better depression treatment in people with Parkinson disease.
Neurology. 94(16):691-692 [DOI] 10.1212/WNL.0000000000009285. [PMID] 32238508.
2020
Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
npj Parkinson's Disease. 6(1) [DOI] 10.1038/s41531-020-0114-4. [PMID] 32550260.
2020
Is Hoarding Behavior Driving the Association Between Obsessive-Compulsive Disorder in Elderly Parkinson Disease Patients?
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 28(2):176-177 [DOI] 10.1016/j.jagp.2019.09.010. [PMID] 31706637.
2020
Lewy Body Degenerations as Neuropsychiatric Disorders.
The Psychiatric clinics of North America. 43(2):361-381 [DOI] 10.1016/j.psc.2020.02.003. [PMID] 32439027.
2019
“Pseudo-syndromes” associated with Parkinson disease, dementia, apathy, anxiety, and depression.
Neurology. Clinical practice. 9(4):354-359 [DOI] 10.1212/CPJ.0000000000000644. [PMID] 31583191.
2019
An association between bipolar disorder and Parkinson disease: When mood makes you move.
Neurology. 92(24):1125-1126 [DOI] 10.1212/WNL.0000000000007641. [PMID] 31118246.
2019
Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson’s disease.
Parkinsonism & related disorders. 64:235-241 [DOI] 10.1016/j.parkreldis.2019.04.006. [PMID] 31053531.
2019
Innovations and Challenges of Training in Geriatric Mental Health.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 27(7):655-659 [DOI] 10.1016/j.jagp.2019.04.017. [PMID] 31122754.
2019
Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 27(7):712-719 [DOI] 10.1016/j.jagp.2019.03.005. [PMID] 30955991.
2019
Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics.
Handbook of clinical neurology. 165:83-121 [DOI] 10.1016/B978-0-444-64012-3.00007-1. [PMID] 31727232.
2019
Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
npj Parkinson's Disease. 5(1) [DOI] 10.1038/s41531-019-0102-8. [PMID] 31840044.
2019
Social role functioning in Parkinson’s disease: A mixed-methods systematic review.
International journal of geriatric psychiatry. 34(8):1128-1138 [DOI] 10.1002/gps.5137. [PMID] 31069845.
2019
Suicide in Parkinson’s disease.
Journal of neurology, neurosurgery, and psychiatry. 90(7):822-829 [DOI] 10.1136/jnnp-2018-319815. [PMID] 30661029.
2018
Absence of Evidence Versus Evidence of Absence-SAPS-PD.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 26(10):1012-1013 [DOI] 10.1016/j.jagp.2018.06.009. [PMID] 30077588.
2018
Clinical Markers of Anxiety Subtypes in Parkinson Disease.
Journal of geriatric psychiatry and neurology. 31(2):55-62 [DOI] 10.1177/0891988718757369. [PMID] 29528763.
2018
Domain-specific cognitive impairment in non-demented Parkinson’s disease psychosis.
International journal of geriatric psychiatry. 33(1):e131-e139 [DOI] 10.1002/gps.4736. [PMID] 28509347.
2018
Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
Parkinsonism & related disorders. 55:8-14 [DOI] 10.1016/j.parkreldis.2018.08.010. [PMID] 30146185.
2018
Efficacy and tolerability of antidepressants in Parkinson’s disease: A systematic review and network meta‐analysis
International Journal of Geriatric Psychiatry. 33(4):642-651 [DOI] 10.1002/gps.4834. [PMID] 29235150.
2018
Markers of impaired motor and cognitive volition in Parkinson’s disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias
Parkinsonism & Related Disorders. 47:50-56 [DOI] 10.1016/j.parkreldis.2017.11.338. [PMID] 29198499.
2018
Markers of impaired motor and cognitive volition in Parkinson’s disease: Correlates of dopamine dysregulation syndrome, impulse control disorder, and dyskinesias
Parkinsonism & Related Disorders. 53:108-109 [DOI] 10.1016/j.parkreldis.2018.04.027.
2018
Onset and Remission of Psychosis in Parkinson’s Disease: Pharmacologic and Motoric Markers.
Movement disorders clinical practice. 5(1):31-38 [DOI] 10.1002/mdc3.12550. [PMID] 29756003.
2018
Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 26(6):700-710 [DOI] 10.1016/j.jagp.2018.01.005. [PMID] 29609901.
2018
Psychosis in Neurodegeneration: Relating Phenomenology to Pathology and Prognosis.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 26(3):314-315 [DOI] 10.1016/j.jagp.2017.11.008. [PMID] 29398353.
2017
Anxiety in Parkinson’s: a complex syndrome of non-dopaminergic and dopaminergic etiology.
European journal of neurology. 24(4):541-542 [DOI] 10.1111/ene.13242. [PMID] 28177179.
2017
Changes in Verbal Fluency in Parkinson’s Disease.
Movement disorders clinical practice. 4(1):84-89 [DOI] 10.1002/mdc3.12421. [PMID] 30713950.
2017
Molecular imaging in neuropsychiatry.
International review of psychiatry (Abingdon, England). 29(6):527-529 [DOI] 10.1080/09540261.2017.1403201. [PMID] 29231768.
2017
Personality and reported quality of life in Parkinson’s disease.
International journal of geriatric psychiatry. 32(3):324-330 [DOI] 10.1002/gps.4475. [PMID] 27059809.
2017
Predictors of anxiety in early-stage Parkinson’s disease – Results from the first two years of a prospective cohort study.
Parkinsonism & related disorders. 43:49-55 [DOI] 10.1016/j.parkreldis.2017.06.024. [PMID] 28711192.
2017
Visual Hallucinations in Neurodegenerative Diseases: Focus on Selective Tissue Vulnerability.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 25(6):605-606 [DOI] 10.1016/j.jagp.2017.02.011. [PMID] 28285770.
2016
Association Between Change in Body Mass Index, Unified Parkinson’s Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
JAMA neurology. 73(3):321-8 [DOI] 10.1001/jamaneurol.2015.4265. [PMID] 26751506.
2016
Cognitive impairment in Parkinson’s disease: Association between patient-reported and clinically measured outcomes.
Parkinsonism & related disorders. 33:107-114 [DOI] 10.1016/j.parkreldis.2016.09.025. [PMID] 27733275.
2016
Gait function and locus coeruleus Lewy body pathology in 51 Parkinson’s disease patients.
Parkinsonism & related disorders. 33:102-106 [DOI] 10.1016/j.parkreldis.2016.09.024. [PMID] 27693194.
2016
Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 24(12):1171-1180 [DOI] 10.1016/j.jagp.2016.08.017. [PMID] 27746069.
2016
The longitudinal impact of depression on disability in Parkinson disease.
International journal of geriatric psychiatry. 31(5):458-65 [DOI] 10.1002/gps.4350. [PMID] 26284815.
2015
Is the Parkinson Anxiety Scale comparable across raters?
Movement disorders : official journal of the Movement Disorder Society. 30(4):545-51 [DOI] 10.1002/mds.26111. [PMID] 25546697.
2015
Molecular imaging of neuropsychiatric symptoms in Alzheimer’s and Parkinson’s disease.
Neuroscience and biobehavioral reviews. 49:157-70 [DOI] 10.1016/j.neubiorev.2014.11.010. [PMID] 25446948.
2015
Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson’s disease.
Neurosurgical focus. 38(6) [DOI] 10.3171/2015.3.FOCUS1523. [PMID] 26030705.
2014
Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 22(12):1410-7 [DOI] 10.1016/j.jagp.2013.09.006. [PMID] 24200594.
2014
Dopamine receptor agonist drugs and impulse control disorders.
JAMA internal medicine. 174(12):1935-7 [DOI] 10.1001/jamainternmed.2014.4097. [PMID] 25329734.
2014
Neuropsychiatric disorders and potentially preventable hospitalizations in a prospective cohort study of older Americans.
Journal of general internal medicine. 29(10):1362-71 [DOI] 10.1007/s11606-014-2916-8. [PMID] 24939712.
2014
REM Sleep Behavior and Motor Findings in Parkinson’s Disease: A Cross-sectional Analysis.
Tremor and other hyperkinetic movements (New York, N.Y.). 4 [DOI] 10.7916/D84B2ZDF. [PMID] 25009765.
2014
Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease.
Parkinsonism & related disorders. 20(7):708-15 [DOI] 10.1016/j.parkreldis.2014.03.020. [PMID] 24780824.
2014
The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale.
Movement disorders : official journal of the Movement Disorder Society. 29(8):1035-43 [DOI] 10.1002/mds.25919. [PMID] 24862344.
2013
Application of depression rating scales in patients with Parkinson’s disease with and without co-Occurring anxiety.
Journal of Parkinson's disease. 3(4):603-8 [DOI] 10.3233/JPD-130264. [PMID] 24275604.
2013
Designing a new scale to measure anxiety symptoms in Parkinson’s disease: item selection based on canonical correlation analysis.
European journal of neurology. 20(8):1198-203 [DOI] 10.1111/ene.12160. [PMID] 23581431.
2013
Dopamine transporter imaging in psychogenic parkinsonism and neurodegenerative parkinsonism with psychogenic overlay: a report of three cases.
Tremor and other hyperkinetic movements (New York, N.Y.). 3 [DOI] 10.7916/D8FB51PS. [PMID] 24137554.
2013
Pharmacologic treatment of anxiety disorders in Parkinson disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 21(6):520-8 [DOI] 10.1016/j.jagp.2012.10.023. [PMID] 23567419.
2013
Screening for DSM-IV-TR cognitive disorder NOS in Parkinson’s disease using the Mattis Dementia Rating Scale.
International journal of geriatric psychiatry. 28(4):364-71 [DOI] 10.1002/gps.3833. [PMID] 22628158.
2012
A comparison of nine scales to detect depression in Parkinson disease: which scale to use?
Neurology. 78(13):998-1006 [DOI] 10.1212/WNL.0b013e31824d587f. [PMID] 22422897.
2012
Prevalence of psychotic symptoms in a community-based Parkinson disease sample.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 20(2):123-32 [DOI] 10.1097/JGP.0b013e31821f1b41. [PMID] 21617521.
2011
Anxiety and self-perceived health status in Parkinson’s disease.
Parkinsonism & related disorders. 17(4):249-54 [DOI] 10.1016/j.parkreldis.2011.01.005. [PMID] 21292531.
2011
Familial aggregation of panic disturbances in Parkinson’s disease.
The Journal of neuropsychiatry and clinical neurosciences. 23(4):417-24 [DOI] 10.1176/jnp.23.4.jnp417. [PMID] 22231313.
2011
Gaps in treatment for anxiety in Parkinson disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 19(10):907-8 [DOI] 10.1097/JGP.0b013e318227fa37. [PMID] 21795961.
2009
Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease.
Movement disorders : official journal of the Movement Disorder Society. 24(9):1333-8 [DOI] 10.1002/mds.22611. [PMID] 19425086.
2006
Clinical features associated with impulse control disorders in Parkinson disease.
Neurology. 67(7):1258-61 [PMID] 17030761.
2003
Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. 8(3):219-26 [PMID] 14510657.

Grants

Jul 2023 ACTIVE
Visual hallucinations and memory impairment in Parkinson's Disease: The role of hippocampal networks
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIVERSITY via NATL INST OF HLTH NIMH
Jul 2023 – May 2024
Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort
Role: Principal Investigator
Funding: JOHNS HOPKINS UNIVERSITY via NATL INST OF HLTH NIA
Sep 2021 ACTIVE
Defining Targets for Tic Detection and Suppression in Tourette Syndrome Deep Brain Stimulation
Role: Co-Investigator
Funding: NATL INST OF HLTH NINDS

Education

MHS, Graduate Training Programs in Clinical Investigation
2016 · Johns Hopkins School of Public Health
Geriatric Psychiatry and Movement Disorders Research Fellow
2008 · Johns Hopkins University
Residency, Medicine/Psychiatry
2006 · Johns Hopkins University
Intern in Medicine/Psychiatry
2003 · Johns Hopkins Bayview
MD
2002 · University of South Florida
BA, Chemistry/Psychology
1996 · University of South Florida

Contact Details

Phones:
Business:
(352) 294-5000
Emails:
Business:
gpontone@ufl.edu
Addresses:
Business Street:
3009 SW WILLISTON RD
GAINESVILLE FL 32608